Charles Schwab’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.6M Buy
2,548,056
+56,976
+2% +$326K ﹤0.01% 1832
2025
Q1
$20.3M Sell
2,491,080
-95,723
-4% -$781K ﹤0.01% 1636
2024
Q4
$24.4M Sell
2,586,803
-80,468
-3% -$758K ﹤0.01% 1595
2024
Q3
$28.5M Buy
2,667,271
+242,672
+10% +$2.59M 0.01% 1495
2024
Q2
$24.1M Buy
2,424,599
+97,672
+4% +$969K ﹤0.01% 1556
2024
Q1
$27.4M Buy
2,326,927
+58,041
+3% +$684K 0.01% 1430
2023
Q4
$32.2M Buy
2,268,886
+90,195
+4% +$1.28M 0.01% 1291
2023
Q3
$26.5M Buy
2,178,691
+72,674
+3% +$884K 0.01% 1310
2023
Q2
$26.5M Buy
2,106,017
+39,859
+2% +$501K 0.01% 1291
2023
Q1
$22.9M Buy
2,066,158
+975
+0% +$10.8K 0.01% 1365
2022
Q4
$25.2M Buy
2,065,183
+44,518
+2% +$544K 0.01% 1270
2022
Q3
$21.1M Buy
2,020,665
+32,529
+2% +$340K 0.01% 1337
2022
Q2
$21.4M Sell
1,988,136
-16,598
-0.8% -$178K 0.01% 1360
2022
Q1
$19M Buy
2,004,734
+47,117
+2% +$446K 0.01% 1590
2021
Q4
$22.6M Buy
1,957,617
+86,684
+5% +$1M 0.01% 1487
2021
Q3
$17.9M Sell
1,870,933
-207,571
-10% -$1.98M 0.01% 1671
2021
Q2
$20M Buy
2,078,504
+57,977
+3% +$559K 0.01% 1586
2021
Q1
$20M Buy
2,020,527
+122,560
+6% +$1.21M 0.01% 1530
2020
Q4
$43.8M Buy
1,897,967
+4,578
+0.2% +$106K 0.02% 847
2020
Q3
$26.7M Sell
1,893,389
-29,778
-2% -$420K 0.01% 1015
2020
Q2
$29M Buy
1,923,167
+84,175
+5% +$1.27M 0.01% 923
2020
Q1
$17M Buy
1,838,992
+188,216
+11% +$1.74M 0.01% 1121
2019
Q4
$16.1M Buy
1,650,776
+107,210
+7% +$1.04M 0.01% 1362
2019
Q3
$12.4M Buy
1,543,566
+100,139
+7% +$803K 0.01% 1473
2019
Q2
$18M Buy
1,443,427
+251,854
+21% +$3.14M 0.01% 1214
2019
Q1
$16.2M Buy
1,191,573
+150,212
+14% +$2.04M 0.01% 1240
2018
Q4
$9.98M Buy
1,041,361
+6,456
+0.6% +$61.9K 0.01% 1459
2018
Q3
$12.5M Buy
1,034,905
+45,899
+5% +$555K 0.01% 1483
2018
Q2
$15.4M Buy
989,006
+77,388
+8% +$1.21M 0.01% 1274
2018
Q1
$13.7M Buy
911,618
+147,843
+19% +$2.22M 0.01% 1267
2017
Q4
$11M Buy
763,775
+31,900
+4% +$459K 0.01% 1406
2017
Q3
$11M Buy
731,875
+138,941
+23% +$2.1M 0.01% 1349
2017
Q2
$5.97M Buy
592,934
+29,983
+5% +$302K 0.01% 1700
2017
Q1
$4.01M Buy
562,951
+30,177
+6% +$215K ﹤0.01% 1883
2016
Q4
$2.65M Buy
532,774
+27,693
+5% +$138K ﹤0.01% 2051
2016
Q3
$3.74M Buy
505,081
+45,280
+10% +$335K ﹤0.01% 1820
2016
Q2
$2.51M Buy
459,801
+48,690
+12% +$266K ﹤0.01% 1952
2016
Q1
$3.47M Buy
411,111
+43,415
+12% +$367K ﹤0.01% 1737
2015
Q4
$3.57M Buy
367,696
+19,590
+6% +$190K ﹤0.01% 1735
2015
Q3
$4.87M Buy
348,106
+195,402
+128% +$2.73M 0.01% 1491
2015
Q2
$2.16M Buy
152,704
+138,904
+1,007% +$1.97M ﹤0.01% 2039
2015
Q1
$151K Hold
13,800
﹤0.01% 2993
2014
Q4
$115K Hold
13,800
﹤0.01% 3050
2014
Q3
$83K Hold
13,800
﹤0.01% 3044
2014
Q2
$47K Sell
13,800
-41,400
-75% -$141K ﹤0.01% 3069
2014
Q1
$115K Hold
55,200
﹤0.01% 3025
2013
Q4
$130K Hold
55,200
﹤0.01% 3034
2013
Q3
$131K Hold
55,200
﹤0.01% 3013
2013
Q2
$131K Buy
+55,200
New +$131K ﹤0.01% 3001